AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Melexis N.V.

Earnings Release Aug 1, 2018

3975_ir_2018-08-01_ebd665de-bae5-487d-bcf9-dab80dbb3b2b.pdf

Earnings Release

Open in Viewer

Opens in native device viewer

Press release - Regulated Information

Melexis Q2 2018 results – Solid growth

Intermediate declaration by the Board of Directors

Ieper, Belgium – August 1st, 2018, 07.00 hrs CET

CONFORM IFRS Q2 2018 Q2 2017 YOY growth Q1 2018 SEQ growth
in k EUR (%) (%)
Sales 141,753 128,343 10% 139,322 2%
Gross result 65,822 59,431 11% 63,110 4%
Gross Margin 46.4% 46.3% 45.3%
EBIT 35,397 33,090 7% 34,335 3%
EBIT in % 25.0% 25.8% 24.6%
EBITDA 45,423 41,792 9% 42,542 7%
EBITDA in % 32.0% 32.6% 30.5%
Net result 28,116 30,806 -9% 28,786 -2%
Net result per share (EPS) 0.70 0.76 0.71
CAPEX 20,080 13,635 20,436

Sales for the second quarter of 2018 were 141.8 million EUR, an increase of 10% compared to the same quarter of the previous year and an increase of 2% compared to the previous quarter.

The EUR/USD exchange rate evolution had a negative impact of 4% compared to the same quarter of last year and a positive impact of 1% compared to the previous quarter.

The gross result was 65.8 million EUR or 46.4% of sales, an increase of 11% compared to the same quarter of last year and an increase of 4% compared to the previous quarter.

R&D expenses were 13.5% of sales, G&A was at 5.3% of sales and Selling was at 2.7% of sales. The operating result was 35.4 million EUR or 25.0% of sales, an increase of 7% compared to the same quarter of last year and an increase of 3% compared to the previous quarter.

The net result was 28.1 million EUR or 0.70 EUR per share, a decrease of 9% compared to 30.8 million EUR or 0.76 EUR per share in the second quarter of 2017 and a decrease of 2% compared to the previous quarter.

CONFORM IFRS HY 2018 HY 2017 YOY growth
in k EUR (%)
Sales 281,075 251,904 12%
Gross result 128,932 116,037 11%
Gross Margin 45.9% 46.1%
EBIT 69,732 64,615 8%
EBIT in % 24.8% 25.7%
EBITDA 87,964 80,537 9%
EBITDA in % 31.3% 32.0%
Net result 56,902 56,249 1%
Net result per share (EPS) 1.41 1.39
CAPEX 40,516 20,025

Sales for the first half year of 2018 were 281.1 million EUR, an increase of 12% compared to the first half year of 2017.

The EUR/USD exchange rate evolution had a negative impact of 6% compared to the first half year of 2017.

Gross result was 128.9 million EUR, an increase of 11% compared to the same period last year.

The operating result was 69.7 million EUR, compared to 64.6 million EUR in the same half year of 2017, an increase of 8%.

Net income was 56.9 million EUR or 1.41 EUR per share, an increase of 1% compared to 56.2 million EUR or 1.39 EUR per share in the first half year of 2017.

Dividend

The Board of Directors decided to pay out an interim dividend of 1.30 EUR gross per share. The Melexis shares will start trading ex coupon on October 23, 2018 (opening of the market). The record date is October 24, 2018 (closing of the market) and the dividend will be payable as from October 25, 2018.

Outlook

Melexis expects sales in the third quarter of 2018 to be around the level of 148 million EUR.

For the full year 2018, Melexis expects sales growth to be between 13% and 14%, a gross profit margin around 45% and an operating margin around 25%, all taking into account a EUR/USD exchange rate of 1.17 for the remainder of the year.

Business comment – Françoise Chombar, CEO:

"I am proud to announce that Melexis second quarter and first half 2018 performance is well in line with our expectations. Excluding strong USD currency headwinds, Melexis first half year sales growth was 18%. The main growth drivers year to date were temperature sensors, embedded lighting and our magnetic sensor product family.

The temperature sensors product line experienced a growing demand from its distribution customer base. These distributors serve a variety of applications in the areas of consumer, white goods and small appliances, mainly targeted for the Asian market. A second growth pillar for the product line is its automotive thermocouple interfaces. These are used in the powertrain and address the growing need for more stringent engine and exhaust thermal management and control.

In embedded lighting, we continue to benefit from existing ambient lighting programs ramping up, as well as new programs which are being added gradually.

The Triaxis® products which form a cornerstone of our magnetic product sensor family are being used in many applications such as steering systems, gear shifters, pedals and transmissions. High demand for electric power steering and advanced powertrain systems, along with the evolution towards autonomous driving, are key drivers for further growth.

Melexis continues to enjoy a positive customer sentiment, translated in a healthy order book further driving our growth in the second half of the year.

Last month, Melexis announced the start of the construction of a new building in Sofia, Bulgaria, which will accommodate increased capacity in test facilities. Also the building expansion in Ieper, Belgium is on schedule. At the end of the year, a new R&D center in Düsseldorf, Germany, will be fully operational. These initiatives demonstrate that Melexis continues to invest both in infrastructure as well as in R&D in order to benefit from the structural growth drivers for our products.

Sales to automotive customers represented 89% of total sales in the second quarter and 90% of total sales in the first half of 2018. The portion of standard product (ASSPs) sales represented 66% o f total sales in the second quarter and 65% of total sales in the first half of 2018."

The statutory auditor PwC Bedrijfsrevisoren bcvba has confirmed that the review, which is substantially complete, has not to date revealed any material misstatement in the draft consolidated accounts, and that the accounting data reported in the press release is consistent, in all material respects, with the draft accounts from which it has been derived.

Financial Calendar

  • Publication Q3 2018 Results: October 24, 2018
  • Dividend pay date: October 25, 2018 (ex coupon on October 23, 2018)
  • Analyst Day: December 5, 2018
  • Publication FY 2018 Results: February 6, 2019

The company's results will be discussed in a conference call on Wednesday, August 1st , 2018 at 17 hrs CET. The conference call will be in English. You have to register for this conference call in advance. You can register by clicking on the following link and filling out the requested information: http://emea.directeventreg.com/registration/2799237 Conference ID: 2799237.

After registration, you will receive the conference call number, a participant user pin, conference pin and instructions on how to join the conference call. For security purposes all participants must register individually if they wish to join the call. A replay number for this call is available for 7 days after the end of the conference call. The replay number for this call is +44 33 33 00 97 85, access code: 2799237.

For further information: Investor Relations Phone: +32 13 67 07 79 Fax: +32 13 67 21 34 Email: [email protected]

About Melexis

Combining a passion for technology with truly inspired engineering, Melexis designs, develops and delivers innovative micro-electronic solutions that enable designers to turn ideas into applications that support the best imaginable future. The company's advanced mixed-signal semiconductor sensor and actuator components address the challenges of integrating sensing, driving and communication into next-generation products and systems that improve safety, raise efficiency, support sustainability and enhance comfort. Melexis is headquartered in Belgium and employs over 1,400 people in 19 locations

worldwide. The company is publicly traded on Euronext Brussels (MELE). For more information, visit www.melexis.com

Disclaimer

Except for those statements that report the Company's historical results, the statements being made are forward looking statements. Actual results could differ materially from those projected in the forward-looking statements. Factors which could cause actual results to differ from expectations include the following: volatility in supply and demand affecting revenues and market prices, price and availability of silicon foundry, assembly and test prices, assembly and test subcontract capacity required to meet financial targets and/or meet backlog requirements, risks and delays associated with bringing up new production capabilities or with deliveries from subcontractors, timing and market acceptance of new products, increased expenses associated with new product acceptance of new products, increased expenses associated with new product introductions of process changes, delays in developing or achieving volume production of new products, which can result in delays or failure to contribute to revenues and profits, ability of the Company to maintain its customer and vendor base and delays in and/or inability in raising additional capital.

Consolidated Income Statement

CONFORM IFRS Quarter ended
30/06/2018
Quarter ended
30/06/2017
Half Year ended
30/06/2018
Half Year ended
30/06/2017
Year ended
31/12/2017
in k EUR audited
Sales 141,753 128,343 281,075 251,904 511,661
Cost of sales -75,931 -68,912 -152,143 -135,867 -276,265
Gross result 65,822 59,431 128,932 116,037 235,396
R&D -19,170 -17,460 -37,690 -34,408 -69,483
G&A -7,447 -5,963 -14,327 -11,535 -23,835
Selling -3,808 -2,917 -7,183 -5,479 -11,660
Other operating result 2,190
Operating result (EBIT) 35,397 33,090 69,732 64,615 132,608
Financial result -820 3,087 294 1,811 3,379
Result before taxes 34,578 36,177 70,027 66,426 135,986
Income taxes -6,462 -5,371 -13,125 -10,177 -25,032
Net result 28,116 30,806 56,902 56,249 110,955
Net result per share in EUR 0.70 0.76 1.41 1.39 2.75

Consolidated Statement of Financial Position

CONFORM IFRS Half Year ended
30/06/2018
Half Year ended
30/06/2017
Year ended
31/12/2017
in k EUR audited
Current Assets :
Cash and cash equivalents 28,763 78,041 75,478
Current investments 154 2,716 415
A/R Trade 75,901 61,733 68,753
A/R from related parties 136 6,177 357
Advance related parties
Assets for current tax 873 680 1,589
Assets held for sale
Other current assets 12,677 13,639 10,121
Inventories 115,271 81,645 97,625
Total current assets 233,776 244,633 254,338
Non-current assets :
Costs of incorporation
Property, plant and equipment 140,515 103,810 116,780
Financial assets 6
Intangible fixed assets 5,370 6,779 5,556
A/R directors
Other non-current assets 5 8 5
Deferred tax assets 25,260 24,896 26,682
Total non current assets 171,149 135,499 149,022
Total assets 404,924 380,132 403,361
CONFORM IFRS Half Year ended Half Year ended Year ended
30/06/2018 30/06/2017 31/12/2017
in k EUR audited
Liabilities and shareholders Equity
Current liabilities :
Bank loans and overdrafts
Derivative financial instruments 397 160
Current portion of LT debt 48 4,005 6,043
A/P trade 25,803 18,903 22,262
Affiliated companies 17,391 12,687 17,449
Accrued taxes 10,523 25,945 36,434
Accrued expenses and payroll 10,367 9,343 10,716
Other current liabilities 4,511 3,130 4,055
Deferred income 1,756 1,220 2,896
Total current liabilities 70,398 75,631 100,015
Non current liabilities :
LT debt less current portion 15,000 11,091 9,043
Deferred tax liabilities
Other non-current liabilities 2,133
Total non current liabilities 15,000 13,224 9,043
Shareholders' equity :
Shareholders' capital 565 565 565
Share premium
Treasury shares -3,818 -3,818 -3,818
Revaluation reserve Hedge -137 -49
Revaluation reserve Fair value
Legal reserve 57 57 57
Retained earnings 271,337 244,497 192,427
Current period's profit 56,902 56,249 110,955
Cumulative translation adjustment -5,527 -6,145 -5,844
Equity attributable to company owners 319,516 291,266 294,292
Non controlling interests 10 10 10
Total shareholders equity 319,526 291,277 294,303
Total liabilities, shareholders' equity 404,924 380,132 403,361
and minority interests

Consolidated Statements of Cash Flow

CONFORM IFRS Quarter ended
30/06/2018
Half Year ended
30/06/2018
Half Year ended
30/06/2017
Year ended
31/12/2017
(in k EUR) audited
Cash flow from operating activities
Net income 28,116 56,902 56,249 110,955
Adjustments for :
Operating activities 12,679 19,804 13,024 18,694
Deferred taxes 810 1,422 -926 -2,712
Capital grants 103 117 427 1,447
Depreciation and amortisation 10,026 18,232 15,922 32,357
Unrealized exchange results 1,172 -838 -2,134 -6,199
Financial result 569 871 -266 -6,199
Operating profit before working capital changes 40,795 76,706 69,272 129,649
A/R, Trade -3,105 -7,127 4,553 -2,560
A/R, affiliates 64 221 -5,759 61
Other current assets -1,172 -1,903 -3,646 -1,990
Other non current assets 1 1 -1 2
Inventories -15,643 -18,911 -7,632 -25,352
A/P 2,715 3,466 -624 2,833
A/P affiliates 386 -58 -1,864 2,898
Accrued expenses 654 8,841 7,270 25,613
Other current liabilities -235 449 575 1,714
Other non current liabilities -13 -1,300 -1,375 -2,069
Interest paid 172 119 -156 -268
Income tax paid -13,850 -35,101 -10,744 -17,226
Cash flow from operating activities 10,768 25,402 49,869 113,306
Cash flow from investing activities
Acquisition of subsidiary, net of cash acquired
Financial fixed assets 6
Purchase of PPE and intangible assets (netted) -20,080 -40,516 -20,025 -46,417
Interest received 2 5 20 102
Investments/proceeds/ from current investments -151 261 -2,558 -256
Investments/proceeds/ from non current investments 2,190
(incl. financial instruments)
Cash provided from investing activities -20,230 -40,250 -22,562 -44,376
Cash flows from financing activities
Payment to acquire own shares
Proceeds/Repayment of long-and short-term debt 6 -37 -42 -50
Proceeds/Repayment of bank loans and overdrafts
Proceeds from (repayment of) related party financing
Impact of exchange results on financing items -1,539 184 3,045 11,153
Dividend payment -32,045 -32,045 -28,038 -80,108
Capital Decrease
Non controlling interests
Cash provided from financing activities -33,578 -31,898 -25,034 -69,005
CTA 4 31 -21 -237
Increase/decrease in cash and cash equivalents -43,036 -46,715 2,252 -312
Cash at beginning of the period 71,798 75,478 75,789 75,789
Cash at the end of the period 28,763 28,763 78,041 75,478

Sales per Geography

Q2/18 Q2/17 Q1/18 HY 2018 HY 2017
APAC
Asia Pacific
48% 48% 49% 49% 48%
EMEA
Europe - Middle-East - Africa
41% 40% 39% 40% 40%
NALA
North America - Latin America
11% 12% 12% 11% 12%
TOTAL 100% 100% 100% 100% 100%

Talk to a Data Expert

Have a question? We'll get back to you promptly.